• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ABBOTT IRELAND DIAGNOSTICS DIVISION ALINITY I CMV IGG REAGENT KIT; ENZYME LINKED IMMUNOABSORBENT ASSAY, CYTOMEGALOVIRUS

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ABBOTT IRELAND DIAGNOSTICS DIVISION ALINITY I CMV IGG REAGENT KIT; ENZYME LINKED IMMUNOABSORBENT ASSAY, CYTOMEGALOVIRUS Back to Search Results
Catalog Number 07P42-22
Device Problem False Negative Result (1225)
Patient Problem No Clinical Signs, Symptoms or Conditions (4582)
Event Date 06/05/2023
Event Type  malfunction  
Manufacturer Narrative
Section a1 - patient identifier: sids = (b)(6).This report is being filed on an international product, alinity i cmv igg, list number 07p42-22, that has a similar product distributed in the us, list number 07p42-24/-33.An evaluation is in process.A follow-up report will be submitted when the evaluation is complete.
 
Event Description
The customer observed false nonreactive alinity i cmv igg result for a pregnant female patient.The patient underwent testing at another facility and the result was reactive.The patient returned on (b)(6) 2023 and repeat testing was performed.The alinity i cmv igg result was still nonreactive.The following data was provided: patient 2: (b)(6) 2023, sid (b)(6), cmv igg result = 0.3 au/ ml (nonreactive).(b)(6) 2023, sid (b)(6), cmv igm result = 0.26 index (nonreactive).Cmv igg result from another facility = reactive.(b)(6) 2023, sid (b)(6), cmv igg result= 0.4 au/ml (nonreactive).(b)(6) 2023, sid (b)(6), cmv igm result= 0.27 index (nonreactive).No impact to patient management was reported.
 
Event Description
The customer observed false nonreactive alinity i cmv igg result for a pregnant female patient.The patient underwent testing at another facility and the result was reactive.The patient returned on (b)(6) 2023 and repeat testing was performed.The alinity i cmv igg result was still nonreactive.The following data was provided: patient 2: (b)(6) 2023 sid (b)(6) cmv igg result = 0.3 au/ ml (nonreactive).(b)(6) 2023 sid (b)(6) cmv igm result = 0.26 index (nonreactive).Cmv igg result from another facility = reactive.(b)(6) 2023 sid (b)(6) cmv igg result= 0.4 au/ml (nonreactive).(b)(6) 2023 sid (b)(6) cmv igm result= 0.27 index (nonreactive).No impact to patient management was reported.
 
Manufacturer Narrative
The complaint investigation for false nonreactive alinity i cmv igg result included a review of data and information provided by the customer, search for similar complaints, ticket trending review, device history record review, and labeling review.In-house testing of retained reagent kit was also completed.Return testing was not completed as returns were not available.Data and information provided by the customer were reviewed and support the complaint issue.Ticket search by lot indicates that the reagent lot performs as expected for this product.Trending review did not identify any trends for the issue for the product.Device history record review did not identify any non-conformances or deviations with lot number 47298fn00 and complaint issue.Labeling was reviewed and found to be adequate.Clinical sensitivity testing was performed using an in-house retained reagent kit of the complaint lot.All specifications were met which indicates the lot is performing as expected.Based on our investigation, no systemic issue or deficiency with the alinity i cmv igg reagent for lot 47298fn00 was identified.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ALINITY I CMV IGG REAGENT KIT
Type of Device
ENZYME LINKED IMMUNOABSORBENT ASSAY, CYTOMEGALOVIRUS
Manufacturer (Section D)
ABBOTT IRELAND DIAGNOSTICS DIVISION
finisklin business park
sligo F91VY 44
EI  F91VY44
Manufacturer (Section G)
ABBOTT IRELAND DIAGNOSTICS DIVISION
finisklin business park
sligo F91VY 44
EI   F91VY44
Manufacturer Contact
siobhan wright
lisnamuck
post market surveillance
longford N39 E-932
EI   N39 E932
433331157
MDR Report Key17341304
MDR Text Key319277664
Report Number3008344661-2023-00128
Device Sequence Number1
Product Code LFZ
Combination Product (y/n)N
Reporter Country CodeIT
PMA/PMN Number
K220949
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Foreign,Health Professional
Reporter Occupation Other Health Care Professional
Type of Report Initial,Followup
Report Date 09/08/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received07/18/2023
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date12/23/2023
Device Catalogue Number07P42-22
Device Lot Number47298FN00
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received08/31/2023
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured02/03/2023
Is the Device Single Use? No
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Treatment
ALNTY I PROCESSING MODU, 03R65-01, AI21321.; ALNTY I PROCESSING MODU, 03R65-01, AI21321.
Patient SexFemale
-
-